Advertisement
Singapore markets close in 7 minutes
  • Straits Times Index

    3,235.16
    -16.55 (-0.51%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,960.65
    +28.67 (+0.36%)
     
  • Bitcoin USD

    70,796.34
    +1,003.71 (+1.44%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Gold

    2,217.60
    +4.90 (+0.22%)
     
  • Crude Oil

    81.83
    +0.48 (+0.59%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,257.17
    -52.92 (-0.72%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

RPC (RES) Q4 Loss Narrower Than Estimates, Revenues Miss

RPC Inc’s RES fourth-quarter 2019 loss of 7 cents was narrower than the Zacks Consensus Estimate of a loss of 10 cents on successful cost-containment efforts.

However, the bottom line compared unfavorably against the year-ago quarter’s earnings of 6 cents per share. The weakness can primarily be attributed to lower activity levels and pricing along with a smaller-fleet of pressure pumping equipment.

Total revenues of $236 million missed the Zacks Consensus Estimate of $242 million. Moreover, the top line declined from the year-ago quarter’s figure of $377 million.

RPC, Inc. Price, Consensus and EPS Surprise

 

RPC, Inc. Price, Consensus and EPS Surprise
RPC, Inc. Price, Consensus and EPS Surprise

RPC, Inc. price-consensus-eps-surprise-chart | RPC, Inc. Quote

ADVERTISEMENT

Segmental Performance

Operating loss in the Technical Services segment totaled $17.1 million against the year-ago quarter’s profit of $19.8 million. The underperformance was mainly caused by lower pricing and activity levels.

Operating profit in the Support Services segment came in at $1.2 million, down from $2.5 million in the year-ago quarter. Seasonal weakness in most of the service lines hurt this segment.

Cost and Expenses

Cost of revenues contracted from $274.4 million in fourth-quarter 2018 to $176.8 million due to lower activity levels and cost-reduction actions.

Financials

RPC’s total capital expenditure in the December quarter of 2019 amounted to $41.4 million. As of Dec 31, the company had cash and cash equivalents of $50 million and no long-term debt.

Outlook

The slowdown in drilling activities in U.S. resources and persistent weakness in crude prices have hurt demand for oilfield services. Although the company has witnessed slight improvement in January and is finishing the month on a strong note, it is uncertain of how things will turn out in the near term.

Zacks Rank & Stocks to Consider

RPC currently carries a Zacks Rank #3 (Hold). Meanwhile, few better-ranked players in the energy space are Murphy Oil Corporation MUR, California Resources Corporation CRC and Suncor Energy SU. All the stocks sport a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Murphy Oil Corporation has trailing four-quarter positive earnings surprise of 37.4%, on average.

California Resources Corporation has trailing four-quarter positive earnings surprise of 711.1%, on average. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters.

Suncor Energy has trailing four-quarter positive earnings surprise of 2.2%, on average. The company’s earnings beat the consensus mark in two of the last four quarters.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Suncor Energy Inc. (SU) : Free Stock Analysis Report
 
RPC, Inc. (RES) : Free Stock Analysis Report
 
California Resources Corporation (CRC) : Free Stock Analysis Report
 
Murphy Oil Corporation (MUR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research